Oral CBD Fails to Relieve Pain from Hand OA & PsA
NEW YORK (Reuters Health)—Lower doses of cannabidiol (CBD) failed to provide any meaningful reduction in pain when added to other analgesic therapy in patients with hand osteoarthritis (OA) or psoriatic arthritis (PsA) in a randomized, placebo-controlled study from Denmark.1 Writing in the journal, Pain, Jonathan Vela, MD, and colleagues of Aalborg University note that CBD... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Reuters Staff Tags: Analgesics Drug Updates cannabidiol (CBD) hand osteoarthritis hand pain PsA Psoriatic Arthritis Source Type: research
More News: Arthritis | Denmark Health | Osteoarthritis | Pain | Psoriatic Arthritis | Rheumatology | Study